By Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Scientist Xinhua Yan works in the lab at Moderna in Cambridge, MA.David L. Ryan/The Boston Globe via Getty Images Latest coronavirus news as of 5 pm on 15 July Moderna coronavirus vaccine candidate deemed safe in first human trial A…
ISSAM AHMED, AFP 15 JULY 2020 The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal. The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the…
The first coronavirus vaccine to be tested in the U.S. boosted the immune systems of the study's participants and is being hailed a major step in the right direction towards eradicating COVID-19.“No matter how you slice this, this is good news,” Dr. Anthony Fauci told The Associated Press.The vaccine, which was developed by researchers at the National…
This story has a long way to go before being over. The story of the tortoise and the hare ranks as one of the most beloved of Aesop's fables. In this fable, the hare gets out to a commanding head start in a race. But the slow-and-steady tortoise ultimately wins. We're seeing a different kind…
On June 26, Dr. Anthony Fauci announced it's "unlikely" that a COVID-19 vaccine with 70-75% efficacy taken by two-thirds of Americans can provide herd immunity to the SARS-CoV-2 coronavirus. His statement has since stirred discussion about America's anti-vaccine movement. A crucial question remains unanswered, however: Is COVID-19 even subject to herd immunity? From universities to…
You don't have permission to access "http://www.medpagetoday.com/meetingcoverage/sabcs/119005" on this server. Reference #18.ac2d3e17.1765724542.59e5bdbf https://errors.edgesuite.net/18.ac2d3e17.1765724542.59e5bdbf
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years